Svs Medicare Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 28-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 28-07-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.50 Cr
as on 28-07-2024
- Revenue -2.74%
(FY 2023)
- Profit -69.76%
(FY 2023)
- Ebitda -32.03%
(FY 2023)
- Net Worth 8.18%
(FY 2023)
- Total Assets 7.70%
(FY 2023)
About Svs Medicare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹17.50 Cr.
Srujan Gaddam, Vandana Dundurapu, Tanmai Gaddam, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290PN2010PTC137138
- Company No.
137138
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Svs Medicare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srujan Gaddam  | Director | 18-Aug-2010 | Current |
| Vandana Dundurapu | Director | 07-May-2012 | Current |
| Tanmai Gaddam | Director | 18-Aug-2010 | Current |
| Ram Dundurapu | Director | 18-Aug-2010 | Current |
Financial Performance and Corporate Structure Insights of Svs Medicare.
Svs Medicare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.74% decrease. The company also saw a substantial fall in profitability, with a 69.76% decrease in profit. The company's net worth moved up by a moderate rise of 8.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svs Medicare?
In 2023, Svs Medicare had a promoter holding of 85.15% and a public holding of 14.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Svs Sourcings Private LimitedActive 6 years 7 monthsSrujan Gaddam and Tanmai Gaddam are mutual person
Balaji Accu-Preci Parts Private LimitedActive 16 years 9 monthsVandana Dundurapu is a mutual person
Mvl Medisynth Private LimitedActive 13 years 26 daysSrujan Gaddam and Tanmai Gaddam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Mar 2023 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 26 Jul 2021 | ₹17.00 Cr | Open |
How Many Employees Work at Svs Medicare?
Unlock and access historical data on people associated with Svs Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svs Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svs Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
